STAT
STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and more
The U.S. is working on rules for investing in China that would likely preserve pharma's ability to strike most licensing deals for Chinese drugs
Ed Silverman
Rights: fair use excerpt

---
Ed Silverman · STAT News · Photo: Alex Hogan/STAT
Source & Credit
Reporting and photography credited as noted above. Originally published by STAT News.
Members only
Checking your membership…